Search
-
Searchresult: Poor prognosis for leukemia patients with trisomy 13Poor prognosis for leukemia patients with trisomy 13 Date: 15.07.2014 Press release content type: Press release
Some cases of acute myeloid leukemia (AML) are accompanied by a mutation which gives patients an extra copy of chromosome 13. This is usually associated with a very unfavorable course of the disease…
Press release -
Searchresult: Federal Health Minister Hermann Gröhe visits the German Cancer Research Center and the National Center for Tumor DiseasesFederal Health Minister Hermann Gröhe visits the German Cancer Research Center and the National Center for Tumor Diseases Date: 10.07.2014 Press release content type: Press release
This year, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) celebrates its 50th anniversary, and the National Center for Tumor Diseases (NCT) Heidelberg celebrates its 10th…
Press release -
Searchresult: First positive results toward a therapeutic vaccine against brain cancerFirst positive results toward a therapeutic vaccine against brain cancer Date: 25.06.2014 Press release content type: Press release
Tumor vaccines might help the body fight cancer. A prerequisite to the development of such a vaccination is to find protein structures in cancer cells that differ from those of healthy cells. Such…
Press release -
Searchresult: Protein test instead of cystoscopy
A recent study from the Heidelberg-based company Sciomics, a spin-off from scientists from the German Cancer Research Center (DKFZ), has presented an advanced method to predict the recurrence of…
Press release -
Searchresult: Cancer genes hijack enhancers
Medulloblastoma is the most common type of malignant brain tumor in children. Unlike most other forms of cancer, it exhibits very few mutations in growth-promoting genes. Thus the reasons for the…
Press release -
Searchresult: Towards individualized cancer medicine for each patient: Dietmar Hopp Foundation will support an initiative at the National Center for Tumor Diseases (NCT) Heidelberg with €15 millionTowards individualized cancer medicine for each patient: Dietmar Hopp Foundation will support an initiative at the National Center for Tumor Diseases (NCT) Heidelberg with €15 million Date: 20.05.2014 Press release content type: Press release
Comprehensive genome analyses of cancer cells have shown that each tumor and cancer patient are unique and need to be treated individually. To pave the way, by 2015 the National Center for Tumor…
Press release -
Searchresult: Blocking cancer stem cells in the brain prolongs survival in miceBlocking cancer stem cells in the brain prolongs survival in mice Date: 16.05.2014 Press release content type: Press release
In a study of malignant brain tumors in mice, scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have identified a key molecule that is responsible for the…
Press release -
Searchresult: Competition among cells prevents cancer
T lymphocytes arise from the thymus gland, which plays an important role in the immune system. In this organ, immature progenitor cells originating in the bone marrow mature into immune system cells.…
Press release -
Searchresult: Exercise and heart disease: (Too) much does not help a lotExercise and heart disease: (Too) much does not help a lot Date: 15.05.2014 Press release content type: Press release
How much physical activity provides the best chances of preventing a new infarction or stroke in heart disease patients? Scientists from the German Cancer Research Center (DKFZ) have discovered that…
Press release -
Searchresult: An "Achilles heel" of acute myeloid leukemiaAn "Achilles heel" of acute myeloid leukemia Date: 07.05.2014 Press release content type: Press release
Heidelberg cancer researchers have found a new target in the treatment of acute myeloid leukemia (AML). A team of scientists headed by Prof. Dr. Stefan Fröhling from the National Center for Tumor…
Press release